Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Cognition Disorders

3,4-dihydroxyphenylglycol has been researched along with Cognition Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoeffer, CA; Klann, E; McBride, SM; Miyawaki, T; Sharma, A; Takayasu, Y; Zukin, RS	1
Goldstein, DS; Holmes, C; Peskind, ER; Raskind, MA	1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylglycol and Cognition Disorders

Article	Year
Dysregulation of mTOR signaling in fragile X syndrome. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-13, Volume: 30, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Animals; CA1 Region, Hippocampal; Carrier Proteins; Cell Cycle Proteins; Cognition Disorders; Disease Models, Animal; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Immunoprecipitation; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; Sirolimus	2010
Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease. Biological psychiatry, 1999, Sep-15, Volume: 46, Issue:6 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine	1999

Article

Year

Dysregulation of mTOR signaling in fragile X syndrome.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jan-13, Volume: 30, Issue:2

Topics: Adaptor Proteins, Signal Transducing; Animals; CA1 Region, Hippocampal; Carrier Proteins; Cell Cycle Proteins; Cognition Disorders; Disease Models, Animal; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Immunoprecipitation; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; Sirolimus

2010

Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.

Biological psychiatry, 1999, Sep-15, Volume: 46, Issue:6

Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aged; Aging; Alzheimer Disease; Antimetabolites; Catechols; Chromatography, High Pressure Liquid; Clonidine; Cognition Disorders; Dihydroxyphenylalanine; Extracellular Space; Female; Humans; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Neuropsychological Tests; Norepinephrine; Yohimbine

1999